These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 35115942

  • 1. Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Xiong L, Zhang H, Guo Y, Song Y, Tao Y.
    Front Pharmacol; 2021; 12():795214. PubMed ID: 35115942
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of vadadustat compared to darbepoetin alfa on anemia in patients with chronic kidney disease: a meta-analysis.
    Huang Q, Liao Z, Liu X, Xia Y, Wang J.
    Int Urol Nephrol; 2023 Feb; 55(2):325-334. PubMed ID: 35960479
    [Abstract] [Full Text] [Related]

  • 3. Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD.
    Nangaku M, Kondo K, Kokado Y, Ueta K, Kaneko G, Tandai T, Kawaguchi Y, Komatsu Y.
    J Am Soc Nephrol; 2021 Jul; 32(7):1779-1790. PubMed ID: 33883252
    [Abstract] [Full Text] [Related]

  • 4. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
    Eckardt KU, Agarwal R, Aswad A, Awad A, Block GA, Bacci MR, Farag YMK, Fishbane S, Hubert H, Jardine A, Khawaja Z, Koury MJ, Maroni BJ, Matsushita K, McCullough PA, Lewis EF, Luo W, Parfrey PS, Pergola P, Sarnak MJ, Spinowitz B, Tumlin J, Vargo DL, Walters KA, Winkelmayer WC, Wittes J, Zwiech R, Chertow GM.
    N Engl J Med; 2021 Apr 29; 384(17):1601-1612. PubMed ID: 33913638
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study.
    Nangaku M, Kondo K, Ueta K, Kokado Y, Kaneko G, Matsuda H, Kawaguchi Y, Komatsu Y.
    Nephrol Dial Transplant; 2021 Aug 27; 36(9):1731-1741. PubMed ID: 33650630
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta-analysis including 13,146 patients.
    Chen H, Cheng Q, Wang J, Zhao X, Zhu S.
    J Clin Pharm Ther; 2021 Aug 27; 46(4):999-1009. PubMed ID: 33615523
    [Abstract] [Full Text] [Related]

  • 7. Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
    Sarnak MJ, Agarwal R, Boudville N, Chowdhury PCP, Eckardt KU, Gonzalez CR, Kooienga LA, Koury MJ, Ntoso KA, Luo W, Parfrey PS, Vargo DL, Winkelmayer WC, Zhang Z, Chertow GM.
    Nephrol Dial Transplant; 2023 Sep 29; 38(10):2358-2367. PubMed ID: 37096396
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
    Koury MJ, Agarwal R, Chertow GM, Eckardt KU, Fishbane S, Ganz T, Haase VH, Hanudel MR, Parfrey PS, Pergola PE, Roy-Chaudhury P, Tumlin JA, Anders R, Farag YMK, Luo W, Minga T, Solinsky C, Vargo DL, Winkelmayer WC.
    Am J Hematol; 2022 Sep 29; 97(9):1178-1188. PubMed ID: 35751858
    [Abstract] [Full Text] [Related]

  • 9. A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease.
    Chen J, Shou X, Xu Y, Jin L, Zhu C, Ye X, Mei Z, Chen P.
    Aging (Albany NY); 2023 Mar 27; 15(6):2237-2274. PubMed ID: 36988549
    [Abstract] [Full Text] [Related]

  • 10. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients.
    Winkelmayer WC, Arnold S, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Parfrey PS.
    Kidney Med; 2023 Jul 27; 5(7):100666. PubMed ID: 37427293
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients.
    Nangaku M, Farag YMK, deGoma E, Luo W, Vargo D, Khawaja Z.
    Nephrol Dial Transplant; 2020 Jul 28. PubMed ID: 32719868
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials.
    Agarwal R, Anand S, Eckardt KU, Luo W, Parfrey PS, Sarnak MJ, Solinsky CM, Vargo DL, Winkelmayer WC, Chertow GM.
    Am J Nephrol; 2022 Jul 28; 53(10):701-710. PubMed ID: 36450264
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
    Chertow GM, Pergola PE, Farag YMK, Agarwal R, Arnold S, Bako G, Block GA, Burke S, Castillo FP, Jardine AG, Khawaja Z, Koury MJ, Lewis EF, Lin T, Luo W, Maroni BJ, Matsushita K, McCullough PA, Parfrey PS, Roy-Chaudhury P, Sarnak MJ, Sharma A, Spinowitz B, Tseng C, Tumlin J, Vargo DL, Walters KA, Winkelmayer WC, Wittes J, Eckardt KU, PRO2TECT Study Group.
    N Engl J Med; 2021 Apr 29; 384(17):1589-1600. PubMed ID: 33913637
    [Abstract] [Full Text] [Related]

  • 18. Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Pergola PE, Spinowitz BS, Hartman CS, Maroni BJ, Haase VH.
    Kidney Int; 2016 Nov 29; 90(5):1115-1122. PubMed ID: 27650732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis.
    Zheng Q, Wang Y, Yang H, Sun L, Zhang P, Zhang X, Guo J, Liu YN, Liu WJ.
    Am J Kidney Dis; 2023 Apr 29; 81(4):434-445.e1. PubMed ID: 36396085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.